|
| Status |
Public on May 09, 2022 |
| Title |
RNA-seq and ATAC-seq of tumor resistance to immune cell attack |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35606086 |
| |
| Submission date |
May 05, 2022 |
| Last update date |
Jun 27, 2022 |
| Contact name |
Claudia GEBHARD |
| E-mail(s) |
claudia.gebhard@gmail.com
|
| Organization name |
UNIVERSITY HOSPITAL REGENSBURG
|
| Street address |
FRANZ-JOSEF-STRAUSS ALLEE 11
|
| City |
REGENSBURG |
| ZIP/Postal code |
93042 |
| Country |
Germany |
| |
|
| Platforms (2) |
|
| Samples (28)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE104112 |
Validation of AS1 as novel regulator of tumor resistance to immune cell attack |
| GSE202304 |
Salt-inducible kinase 3 protects tumor cells from cytotoxic T cell attack by promoting TNF-induced NF-κB activation |
|
| Relations |
| BioProject |
PRJNA836528 |
Less...
More...